Search for a networks
Safety and dose finding study of different MOD-4023 dose levelscompared to daily r-hGH therapy in pre-pubertal growth hormonedeficient children
- Type of network : Multinational clinical trials
- Geographic coverage : European
- Funding body(ies) : OPKO BIOLOGICS LTD.
- Sponsor : Information not provided
Coordinator of multinational clinical trial
- INFORMATION NOT PROVIDED
- OPKO Biologics Ltd.
- 16 Ashlagan st.
- 8211804 KIRYAT GAT
- More information
- Phone : 00972-8-9300051
- Fax : -
Last update: March 2018
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.